Composition
- Active ingredients
- SODIUM PHENYLBUTYRATE 3GM/PACKET; TAURURSODIOL 1GM/PACKET
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA216660.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Relyvrio
- Active substance
- sodium phenylbutyrate
- Route
- Oral
- Dosage form
- For suspension
- Applicant
- Amylyx
- Status
- Discontinued
- FDA approval
- 29 Sept 2022
- Application
- NDA216660-001